APTV vs REGN · P/E 41, rev $19.71B vs P/E 14, rev $14.34B
Aptiv PLC (APTV) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the APTV and REGN stock pages for the full models.
Not investment advice.